Merck Gets PTAB To Nix Johns Hopkins Cancer Drug Patent
Merck & Co. Inc. subsidiary Merck Sharp & Dohme LLC has notched a win at the Patent Trial and Appeal Board in its disagreement with Johns Hopkins University over a cancer research...To view the full article, register now.
Already a subscriber? Click here to view full article